TITLE

Human Papillomavirus and Vaccination

AUTHOR(S)
Huang, Christine M.
PUB. DATE
June 2008
SOURCE
Mayo Clinic Proceedings;Jun2008, Vol. 83 Issue 6, p701
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States. Modeling estimates suggest that more than 80% of sexually active women will have acquired genital HPV by age 50 years. Although most infections are transient and asymptomatic, persistent infection with high-risk types of HPV can lead to precancerous lesions and progress to cancer. In June 2006, the US Food and Drug Administration licensed the first vaccine to prevent cervical cancers and other diseases in women. This quadrivalent vaccine protects against HPV-6, HPV-11, HPV-16, and HPV-18, which are responsible for 70% of cervical cancers and 90% of genital warts. Several studies have been published examining the vaccine's efficacy, duration, immunogenicity, and safety. Questions and controversy remain regarding mandatory vaccination, need for booster doses, and cost-effectiveness.
ACCESSION #
32617218

 

Related Articles

  • A SHOT AGAINST CANCER. Gorman, Christine // Time;6/19/2006, Vol. 167 Issue 25, p66 

    The article discusses a new vaccine against cervical cancer called Gardasil, which has been approved by the U.S. Food and Drug Administration. The author describes what cervical cancer is and how it develops. Gardasil, developed by Merck, protects against the two most common cancer-causing...

  • Poll says most Americans back HPV vaccine.  // Contemporary OB/GYN;Oct2006, Vol. 51 Issue 10, p25 

    The article reveals that U.S. citizens favor the use of the vaccine Gardasil to prevent human papillomavirus (HPV) as of October 2006. The U.S. Food and Drug Administration has approved the HPV vaccine and recommends that the vaccine be administered to women between 9 to 26 years old. The...

  • GETTING VACCINATED AGAINST HPV: ATTITUDES, INTENTIONS AND PERCEIVED BARRIERS OF FEMALE UNDERGRADUATES. Burke, Sloane C.; Vail-Smith, Karen; White, David M.; Baker, Elizabeth; Mitchell, Terri // College Student Journal;Mar2010, Vol. 44 Issue 1, p55 

    This study examines college women's intention to receive the Human Papilloma Virus (HPV) vaccine and their perceived barriers to being vaccinated. The study reports findings from an online questionnaire completed by 856 undergraduate women enrolled in a required personal health course at a large...

  • Assessing the HPV Vaccine: Researchers Confront Complex Interplay of Factors. Tuma, Rabiya S. // JNCI: Journal of the National Cancer Institute;4/1/2009, Vol. 101 Issue 7, p444 

    The article focuses on the issues regarding the effects of human papillomavirus (HPV) vaccine. It states that the HPV vaccine, which protects women from developing pre-cancerous cervix lesions, has already been administered by the U.S. Food and Drug Administration (FDA) and the Centers for...

  • HPV vaccine could save millions of lives. Mitrzyk, Beatriz Manzor // Pharmacy Today;Aug2006, Vol. 12 Issue 8, p11 

    The article offers information on the human papillomavirus vaccine (Gardasil) manufactured by Merch & Co. Inc. Gardasil has been found to prevent cervical cancer and genital warts. The U.S. Food and Drug Administration licensed the vaccine for girls and women from between 9 to 26 years old....

  • MIND THE PAP.  // Women's Health;Oct2008, Vol. 5 Issue 8, p32 

    The article reports that the U.S. Food and Drug Administration (FDA) still had questions about the effectiveness of the Gardasil vaccine against certain types of human papillomavirus in the older age group. In early 2008, researchers had found Gardasil to be effective for women up to age 45....

  • FDA expands HPV vaccine approval for prevention of vulvar, vaginal cancers. Block, Stan L. // Infectious Diseases in Children;Oct2008, Vol. 21 Issue 10, p9 

    The article reports that the U.S. Food and Drug Administration (FDA) has approved the human papillomavirus (HPV) quadrivalent vaccine for the prevention of vaginal and vulvar cancers caused by HPV types 16 and 18 in girls and women aged 9 to 26 years. Doctor Jesse L. Goodman, director of the FDA...

  • Health officials consider HPV vaccination for males.  // Infectious Diseases in Children;Sep2009, Vol. 22 Issue 9, p1 

    The article reports on the factors which need to be considered by the Advisory Committee on Immunization Practices (ACIP) and the U.S. Food and Drug Administration regarding the extension of the human papillomavirus vaccine to boys and young men.

  • HPV vaccine update: Will there be more options for women and men?  // Contraceptive Technology Update;Nov2009, Vol. 30 Issue 11, p121 

    The article reports on the move of the U.S. Food and Drug Administration (FDA) to review the effectiveness of human papillomavirus (HPV) vaccine for the prevention of cervical cancer.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics